Evidence map›Paper›PMID 23520517›Full record

ArticlePloS one2013

Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.

Jeffrey L Voorhees, Andrew J Tarr, Eric S Wohleb, Jonathan P Godbout, Xiaokui Mo, John F Sheridan, Timothy D Eubank, Clay B Marsh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
5.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 234 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Early-life internalizing behavioral trajectories and childhood-onset asthma: An epigenetic link.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  5. Article
  6. Immunity in Rodent Models of Stress.Biological psychiatry · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jeffrey L VoorheesThe Dorothy M. Davis Heart and Lung Research Institute, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Andrew J Tarr
Eric S Wohleb
Jonathan P Godbout
Xiaokui Mo
John F Sheridan
Timothy D Eubank
Clay B Marsh
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI WANCAI YANG · 1985 to 2026
$132.3M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
NF-kappaB:an Akt target &regulator of monocyte survivalR01HL067176 · NHLBI · OHIO STATE UNIVERSITY · PI MARSH, CLAY B · 2001 to 2011
$3.2M
MOLECULAR MECHANISMS OF LUNG INFLAMMATIONT32HL007946 · NHLBI · OHIO STATE UNIVERSITY · PI WEWERS, MARK DAMIAN · 2000 to 2017
$3.1M
The role of the miR-17-92 microRNA cluster in the pathogenesis of IPFR01HL102464 · NHLBI · OHIO STATE UNIVERSITY · PI MARSH, CLAY B · 2010 to 2013
$1.5M
NCATS NIH HHS UL1 TR000090NCI NIH HHS P30 CA016058NHLBI NIH HHS R01 HL067176NHLBI NIH HHS R01 HL102464NHLBI NIH HHS T32 HL007946NHLBI NIH HHS T32 HL07946
6 · The paper itself

Abstract

Altered inflammatory cytokine profiles are often observed in individuals suffering from major depression. Recent clinical work reports on elevated IL-6 and decreased IL-10 in depression. Elevated IL-6 has served as a consistent biomarker of depression and IL-10 is proposed to influence depressive behavior through its ability to counterbalance pro-inflammatory cytokine expression. Clinical and animal studies suggest a role for IL-10 in modifying depressive behavior. Murine restraint stress (RST) is regularly employed in the study of behavioral and biological symptoms associated with depressive disorders. While responses to acute RST exposure have been widely characterized, few studies have examined the ongoing and longitudinal effects of extended RST and fewer still have examined the lasting impact during the post-stress period. Consistent with clinical data, we report that a protocol of prolonged murine RST produced altered cytokine profiles similar to those observed in major depressive disorder. Parallel to these changes in circulating cytokines, IL-10 mRNA expression was diminished in the cortex and hippocampus throughout the stress period and following cessation of RST. Moreover, chronic RST promoted depressive-like behavior throughout the 28-day stress period and these depressive-like complications were maintained weeks after cessation of RST. Because of the correlation between IL-10 suppression and depressive behavior and because many successful antidepressant therapies yield increases in IL-10, we examined the effects of IL-10 treatment on RST-induced behavioral changes. Behavioral deficits induced by RST were reversed by exogenous administration of recombinant IL-10. This work provides one of the first reports describing the biological and behavioral impact following prolonged RST and, taken together, this study provides details on the correlation between responses to chronic RST and those seen in depressive disorders.

Indexed as

AnimalsBehavior, AnimalDepressionImmobilizationInterleukin-10Interleukin-6MiceRecombinant ProteinsStress, PhysiologicalTime FactorsIL10 protein, mouseInterleukin-10Interleukin-6Recombinant Proteins

Identifiers

PMID23520517
PMCPMC3592793
OpenAlexW2044404835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.